interventional cardiology
Adjust Font Size: Decrease Increase

Pre-Clinical Trial Results

Controlled and prolonged elution kinetics and efficient drug transfer to arteries.

MiStent SES's unique coating formulation and technology delivers a controlled and sustained release of a drug from a fully-absorbable coating. This differentiated method of target drug delivery has already shown promising results related to safety and prolonged elution kinetics in pre-clinical porcine trials.

[N.B.: Not included here - porcine coronary artery implants cross-sections]

Clinical significance in humans is unknown.

Caution: The MiStent SES has received CE marking but is not approved in the USA or any other countries. Any other products described on this website are investigational devices that are not available for sale in any country.
Home | About Us | Therapeutic Focus | Product Pipeline | Technology | News | Terms of Use | Privacy Policy | Site Map
© 2014 Micell Technologies, Inc. All rights reserved.
"Micell", "MiStent", and "MiStent SES" are registered trademarks of Micell Technologies, Inc.